Immunotherapy: HLA genotype: good to be different
Nature Reviews Immunology 18, 78 (2018).
doi:10.1038/nri.2017.220
Author: Kirsty Minton
HLA class I homozgosity and loss of heterozygosity are associated with poor response to checkpoint blockade therapy.
Source: Nature Reviews Immunology - Category: Allergy & Immunology Authors: Kirsty Minton Tags: Research Highlight Source Type: research
More News: Allergy & Immunology | Immunotherapy